Efficacy of Prophylactic Internal Iliac Artery Balloon Catheterization in the Management of Placenta Previa and Accreta
Primary Purpose
Placenta Previa, Placenta Accreta
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
prophylactic internal iliac artery balloon catheterization
Prophylactic internal iliac artery balloon
Radiology operation
Sponsored by
About this trial
This is an interventional treatment trial for Placenta Previa
Eligibility Criteria
Inclusion Criteria:
- Pregnant women were eligible if they were diagnosed to have placenta previa and accreta by sonographic examination or Magnetic Resonance Imaging.
Exclusion Criteria:
- Any case who had bleeding disorder or underwent emergency cesarean delivery was excluded.
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
No Intervention
Arm Label
Balloon group
Control group
Arm Description
Prophylactic Internal Iliac Artery Balloon Catheterization
no intervention
Outcomes
Primary Outcome Measures
blood loss
Secondary Outcome Measures
operation duration
fluid transfusion
blood transfusion
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT02966197
Brief Title
Efficacy of Prophylactic Internal Iliac Artery Balloon Catheterization in the Management of Placenta Previa and Accreta
Official Title
the Efficacy of Prophylactic Internal Iliac Artery Balloon Catheterization in the Management of Placenta Previa and Accreta
Study Type
Interventional
2. Study Status
Record Verification Date
November 2016
Overall Recruitment Status
Completed
Study Start Date
June 2015 (undefined)
Primary Completion Date
September 2016 (Actual)
Study Completion Date
September 2016 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor-Investigator
Name of the Sponsor
Deng Dongrui
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
Placenta previa and accreta both could potentially cause serious postpartum hemorrhage and even maternal death. Interventional radiological techniques have been developed to limit massive hemorrhage during caesarean section. This study investigated the efficacy of prophylactic internal iliac artery balloon catheterization in management for placenta previa and accreta.
Detailed Description
Placenta previa and accreta both could potentially cause serious postpartum hemorrhage and even maternal death. Interventional radiological techniques have been developed to limit massive hemorrhage during caesarean section. This study investigated the efficacy of prophylactic internal iliac artery balloon catheterization in management for placenta previa and accreta. Between June 2015 and August 2016,patients were personally recruited and managed by the authors,and assigned to either balloon group or control group by their willingness to catheterization or not. Both groups benefitted similar management protocol with the exception of interventional radiology operation. Intraoperative blood loss, transfusion volume, radiation dose, exposure time, surgical duration, procedure complications and neonatal outcomes were analyzed.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Placenta Previa, Placenta Accreta
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
114 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Balloon group
Arm Type
Experimental
Arm Description
Prophylactic Internal Iliac Artery Balloon Catheterization
Arm Title
Control group
Arm Type
No Intervention
Arm Description
no intervention
Intervention Type
Procedure
Intervention Name(s)
prophylactic internal iliac artery balloon catheterization
Intervention Description
Between June 2015 and August 2016
Intervention Type
Device
Intervention Name(s)
Prophylactic internal iliac artery balloon
Intervention Type
Radiation
Intervention Name(s)
Radiology operation
Primary Outcome Measure Information:
Title
blood loss
Time Frame
intraoperative
Secondary Outcome Measure Information:
Title
operation duration
Time Frame
intraoperative
Title
fluid transfusion
Time Frame
intraoperative
Title
blood transfusion
Time Frame
intraoperative
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
15 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
Pregnant women were eligible if they were diagnosed to have placenta previa and accreta by sonographic examination or Magnetic Resonance Imaging.
Exclusion Criteria:
Any case who had bleeding disorder or underwent emergency cesarean delivery was excluded.
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Learn more about this trial
Efficacy of Prophylactic Internal Iliac Artery Balloon Catheterization in the Management of Placenta Previa and Accreta
We'll reach out to this number within 24 hrs